NSIM
NVO

North Star Investment Management’s Novo Nordisk NVO Stock Holding History

North Star Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.5K Sell
966
-530
-35% -$25.1K ﹤0.01% 808
2025
Q4 		$76.1K Sell
1,496
-558
-27% -$28.5K ﹤0.01% 594
2025
Q3 		$114K Sell
2,054
-888
-30% -$52K 0.01% 511
2025
Q2 		$203K Sell
2,942
-17,800
-86% -$1.21M 0.01% 417
2025
Q1 		$1.44M Buy
20,742
+3,200
+18% +$264K 0.1% 187
2024
Q4 		$1.51M Buy
17,542
+17,050
+3,465% +$1.84M 0.11% 178
2024
Q3 		$58.6K Buy
492
+2
+0.4% +$267 ﹤0.01% 577
2024
Q2 		$69.9K Buy
490
+1
+0.2% +$133 0.01% 550
2024
Q1 		$62.8K Buy
489
+189
+63% +$22.5K ﹤0.01% 577
2023
Q4 		$31K Hold
300
– – ﹤0.01% 663
2023
Q3 		$27.3K Hold
300
– – ﹤0.01% 689
2023
Q2 		$24.3K Hold
300
– – ﹤0.01% 718
2023
Q1 		$23.9K Buy
300
+100
+50% +$7.09K ﹤0.01% 736
2022
Q4 		$13.5K Hold
200
– – ﹤0.01% 805
2022
Q3 		$10K Hold
200
– – ﹤0.01% 805
2022
Q2 		$11K Sell
200
-400
-67% -$22.2K ﹤0.01% 808
2022
Q1 		$33K Hold
600
– – ﹤0.01% 665
2021
Q4 		$34K Hold
600
– – ﹤0.01% 690
2021
Q3 		$29K Hold
600
– – ﹤0.01% 688
2021
Q2 		$25K Buy
600
+400
+200% +$15.5K ﹤0.01% 706
2021
Q1 		$7K Hold
200
– – ﹤0.01% 863
2020
Q4 		$7K Hold
200
– – ﹤0.01% 832
2020
Q3 		$7K Hold
200
– – ﹤0.01% 804
2020
Q2 		$7K Hold
200
– – ﹤0.01% 772
2020
Q1 		$6K Buy
+200
New +$5.96K ﹤0.01% 797
2017
Q4 		– Sell
-700
Closed -$17K – 1094
2017
Q3 		$17K Hold
700
– – ﹤0.01% 740
2017
Q2 		$15K Sell
700
-136
-16% -$2.74K ﹤0.01% 758
2017
Q1 		$14K Buy
836
+136
+19% +$2.37K ﹤0.01% 747
2016
Q4 		$13K Hold
700
– – ﹤0.01% 713
2016
Q3 		$15K Hold
700
– – ﹤0.01% 576
2016
Q2 		$19K Hold
700
– – ﹤0.01% 541
2016
Q1 		$19K Hold
700
– – ﹤0.01% 516
2015
Q4 		$20K Buy
+700
New +$19.4K ﹤0.01% 505

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

North Star Investment Management's NVO Position: Q1 2026 in Review

North Star Investment Management reduced its Novo Nordisk (NVO) stake by 35% in Q1 2026, selling an estimated $25.1K and leaving 966 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

North Star Investment Management first reported a position in NVO in Q4 2015 and has held it in 33 quarters since. The position peaked at $1.51M in Q4 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • North Star Investment Management held 966 shares of Novo Nordisk worth $35.5K as of Q1 2026.
  • North Star Investment Management sold 530 Novo Nordisk shares in Q1 2026, an estimated $25.1K.
  • Novo Nordisk made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #808 holding.
  • North Star Investment Management first reported a position in Novo Nordisk in Q4 2015 and has held it in 33 quarters since.
  • North Star Investment Management's Novo Nordisk position peaked at $1.51M in Q4 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.